ANI Pharmaceuticals, Inc.
ANIP
$69.82
$0.180.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.52M | -7.09M | 27.02M | 35.55M | 18.78M |
| Total Depreciation and Amortization | 67.73M | 60.33M | 59.78M | 59.78M | 59.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.99M | 15.04M | 7.16M | 4.07M | 15.53M |
| Change in Net Operating Assets | -11.19M | 24.62M | 18.63M | 16.41M | 24.86M |
| Cash from Operations | 64.02M | 92.90M | 112.59M | 115.80M | 118.96M |
| Capital Expenditure | -16.24M | -16.12M | -13.05M | -11.10M | -8.87M |
| Sale of Property, Plant, and Equipment | 13.51M | 13.51M | 13.51M | 13.51M | -- |
| Cash Acquisitions | -401.28M | -393.08M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -717.00K | -3.13M | -5.31M | -9.64M | -9.64M |
| Cash from Investing | -404.72M | -398.82M | -4.85M | -7.23M | -18.51M |
| Total Debt Issued | 641.25M | 641.25M | -- | -- | -- |
| Total Debt Repaid | -296.03M | -296.63M | -3.00M | -3.00M | -3.00M |
| Issuance of Common Stock | 6.49M | 6.76M | 11.15M | 91.99M | 89.55M |
| Repurchase of Common Stock | -10.96M | -10.87M | -10.86M | -10.10M | -4.99M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M |
| Other Financing Activities | -74.18M | -80.95M | -25.00M | -25.00M | -12.50M |
| Cash from Financing | 264.95M | 257.93M | -29.34M | 52.26M | 67.44M |
| Foreign Exchange rate Adjustments | -470.00K | -75.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.23M | -48.06M | 78.40M | 160.84M | 167.89M |